APA (7th ed.) Citation

Giannitsis, E., Garfias-Veitl, T., Slagman, A., Searle, J., Müller, C., Blankenberg, S., . . . Möckel, M. (2022). Biomarkers-in-cardiology 8 RE-VISITED: Consistent safety of early discharge with a dual marker strategy combining a normal hs-cTnT with a normal copeptin in low-to-intermediate risk patients with suspected acute coronary syndrome : a secondary analysis of the randomized biomarkers-in-cardiology 8 trial. Cells, 11(2), . https://doi.org/10.3390/cells11020211

Chicago Style (17th ed.) Citation

Giannitsis, Evangelos, et al. "Biomarkers-in-cardiology 8 RE-VISITED: Consistent Safety of Early Discharge with a Dual Marker Strategy Combining a Normal Hs-cTnT with a Normal Copeptin in Low-to-intermediate Risk Patients with Suspected Acute Coronary Syndrome : A Secondary Analysis of the Randomized Biomarkers-in-cardiology 8 Trial." Cells 11, no. 2 (2022). https://doi.org/10.3390/cells11020211.

MLA (9th ed.) Citation

Giannitsis, Evangelos, et al. "Biomarkers-in-cardiology 8 RE-VISITED: Consistent Safety of Early Discharge with a Dual Marker Strategy Combining a Normal Hs-cTnT with a Normal Copeptin in Low-to-intermediate Risk Patients with Suspected Acute Coronary Syndrome : A Secondary Analysis of the Randomized Biomarkers-in-cardiology 8 Trial." Cells, vol. 11, no. 2, 2022, https://doi.org/10.3390/cells11020211.